StockData
RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29

REVVITY, INC.

Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Aug 11, 2026
$150.94−1.70 (-1.11%)

Close on Oct 19, 2026

Market cap
$16.85B
P/E (TTM)
71.9
Dividend yield
0.19%

Earnings

Next report expected Oct 26, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jul 5, 2026
Aug 4, 2026Before market open$730.00M$0.48$1.41
Q1 FY2026
Ended Apr 5, 2026
May 5, 2026Before market open$711.00M$0.37$1.06
Q4 FY2025
Ended Dec 28, 2025
Feb 2, 2026Before market open$772.00M$0.87$1.70
Q3 FY2025
Ended Sep 28, 2025
Oct 27, 2025Before market open$699.00M$0.40$1.18
Q2 FY2025
Ended Jun 29, 2025
Jul 28, 2025Before market open$720.00M$0.46$1.18
Q1 FY2025
Ended Mar 30, 2025
Apr 28, 2025Before market open$665.00M$0.35$1.01
Q4 FY2024
Ended Dec 29, 2024
Jan 31, 2025Before market open$729.00M$0.78$1.42
Q3 FY2024
Ended Sep 29, 2024
Nov 4, 2024Before market open$684.00M$0.77$1.28
Q2 FY2024
Ended Jun 30, 2024
Jul 29, 2024Before market open–––
Q1 FY2024
Ended Mar 31, 2024
Apr 29, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 1, 2024Before market open–––

Company guidance

Outlook given with results on Aug 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
pro forma adjusted earnings per sharenon-GAAPfull year 2026$5.30 to $5.40Raised
pro forma organic revenue growthnon-GAAPfull year 20264% to 5% growthRaised
total revenuefull year 2026$2.83B to $2.86BRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Revvity filed with the SEC